Conversion therapy for unresectable hepatocellular carcinoma: Advances and challenges

被引:0
|
作者
He, Yan-Fei [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 6, Dept Hlth Management Ctr, 6 Fucheng Rd, Beijing 100048, Peoples R China
关键词
Unresectable hepatocellular carcinoma; Conversion therapy; Challenges; Advances; Advanced hepatocellular carcinoma; Targeted therapy; Immunotherapy; PORTAL-VEIN LIGATION; RADIOFREQUENCY ABLATION; HEPATIC RESECTION; SORAFENIB; CHEMOTHERAPY; BEVACIZUMAB; COMBINATION; EFFICACY; PLUS;
D O I
10.4251/wjgo.v16.i10.4289
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recently, the World Journal of Gastrointestinal Oncology published an article entitled "Pathologically successful conversion hepatectomy for advanced giant hepatocellular carcinoma after multidisciplinary therapy: A case report and review of the literature", in which the authors shared their successful experience with complete surgical resection after multidisciplinary conversion therapy. The study by Chu et al demonstrates the great challenges that the advanced hepatocellular carcinoma (HCC) poses to surgical oncology, reveals the complexity of conversion therapy for unresectable HCC, emphasizes the important role of a multidisciplinary management model in conversion therapy, and enriches our understanding of the dynamics of personalized treatment for different patients. At present, conversion therapy is a hot research topic in the treatment of unresectable HCC, which has brought new hope to many patients with moderately advanced HCC. However, there are still many urgent problems to be solved in conversion therapy. Here, we would like to further discuss the advances and challenges of conversion therapy for unresectable HCC with the authors and the general readers.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Resection of unresectable hepatocellular carcinoma after conversion therapy with apatinib and camrelizumab: a case report and literature review
    Liu, Xin-Liang
    Li, Xiang-Ze
    Chu, Yi-Fu
    Liu, Feng
    Tian, Hu
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [32] Successful conversion therapy for unresectable hepatocellular carcinoma is getting closer: A systematic review and meta-analysis
    Pei, Yinxuan
    Li, Weiwei
    Wang, Zixiang
    Liu, Jinlong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [33] Conversion therapy of stage IVb unresectable gallbladder carcinoma
    Ning, Cong
    Zhang, Xinmu
    Yang, Xiaobo
    Sang, Xinting
    Zhao, Haitao
    Wang, Hanping
    HEPATOBILIARY SURGERY AND NUTRITION, 2022, 11 (02) : 335 - 337
  • [34] Inflammation-related nomogram for predicting survival of patients with unresectable hepatocellular carcinoma received conversion therapy
    Jia-Lin Wu
    Jun-Yang Luo
    Zai-Bo Jiang
    Si-Bo Huang
    Ge-Run Chen
    Hui-Ying Ran
    Qi-Yue Liang
    Ming-Sheng Huang
    Li-Sha Lai
    Jun-Wei Chen
    World Journal of Gastroenterology, 2023, (20) : 3168 - 3184
  • [35] A Retrospective Analysis of Conversion Therapy with Lenvatinib, Sintilimab, and Arterially-Directed Therapy in Patients with Initially Unresectable Hepatocellular Carcinoma
    Gan, Leijuan
    Lang, Mengran
    Tian, Xindi
    Ren, Shaohua
    Li, Guangtao
    Liu, Yayue
    Han, Ruyu
    Zhu, Kangwei
    Li, Huikai
    Wu, Qiang
    Cui, Yunlong
    Zhang, Wei
    Fang, Feng
    Li, Qiang
    Song, Tianqiang
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 673 - 686
  • [36] From Conversion to Resection for Unresectable Hepatocellular Carcinoma: A Review of the Latest Strategies
    Liang, Chen
    He, Zhaoqian
    Tao, Qiang
    Tang, Xiang
    Jiang, Lingmin
    Tu, Xinyue
    Liu, Zonghao
    Chen, Hua
    Xie, Feihu
    Zheng, Yun
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (24)
  • [37] Conversion therapy and maintenance therapy for primary hepatocellular carcinoma
    Zhou, Hongyuan
    Song, Tianqiang
    BIOSCIENCE TRENDS, 2021, 15 (03) : 155 - 160
  • [38] Challenges for Measuring Cost-effectiveness of Immunotherapy in Unresectable Hepatocellular Carcinoma
    Wagle, Nikita Sandeep
    Spencer, Jennifer C.
    JAMA NETWORK OPEN, 2021, 4 (04)
  • [39] Therapeutic Strategies for Hepatocellular Carcinoma: New Advances and Challenges
    Sílvia Vilarinho
    Tamar Taddei
    Current Treatment Options in Gastroenterology, 2015, 13 (2) : 219 - 234
  • [40] Advances and challenges in laparoscopic surgery in the management of hepatocellular carcinoma
    Ziogas, Ioannis A.
    Tsoulfas, Georgios
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2017, 9 (12): : 233 - 245